The tumor promoting role of FBXO22 has been presented by some reports in liver cancer35, lung cancer37, and breast cancer39, while an inhibitory role towards cancer metastasis has also been proposed in lung cancer34 and breast cancer39. This evidence concerns the gene FBXO22 and neoplasm.